U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: April 7-13, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: April 7-13, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 04/07/2024
Location: Atlanta, GA
Subject: American College of Cardiology 2024 Federal Cardiology Section Meeting and Lunch
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia and other invited attendees

Event Date: 04/08/2024
Location: Atlanta, GA
Subject: American College of Cardiology 73rd Annual Scientific Session: Time for a Revamp of the Clinical Evidence System
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, media, and other invited attendees

Event Date: 04/10/2024
Location: Washington, DC
Subject: Alliance for a Stronger FDA; Reception to Celebrate Dr. Janet Woodcock's FDA Career
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, media, and other invited guests

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

Event Date: 04/11/2024
Location: Washington, DC
Subject: Duke-Margolis Health Policy Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Fyodor Urnov (University of California Berkley); Monica Bertagnolli (National Institutes of Health); Dora Hughes (Centers for Medicare and Medicaid Services); Adrian Hernandez (Duke University/Duke Clinical Research Institute); Roy Herbst (Yale School of Medicine);

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 04/08/2024
Location: College Park, MD
Subject: Plant Biotechnology
FDA Participant/Group: KRISTI MULDOON JACOBS; DAVID EDWARDS; JESSICA ROWDEN;
Non FDA Participant/Group: Beth Ellikidis, Leah Buchman (Biotechnology Innovation Organization); Andy LaVigne, Fan-Li Chou (American Seed Trade Association); Rebeckah Adcock (International Fresh Produce Association);

Event Date: 04/09/2024
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: LAURA PILLSBURY; KARI BARRETT;
Non FDA Participant/Group: Eric Schlosser, Melissa Robledo, Michael Pollan, Robert Kenner (Producer of Food, Inc 2); Scott Faber (Environmental Working Group);

Event Date: 04/09/2024
Location: Washington, DC
Subject: Washington Agricultural Roundtable; Speaker: Human Foods Program Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Several attendees from industry, trade associations, consulting firms, and federal government

Event Date: 04/11/2024
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Safe Food Coalition to include consumer, public health, research, and labor organizations

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 04/08/2024
Location: Virtual
Subject: Emerging Issues
FDA Participant/Group: N/A
Non FDA Participant/Group: Dr. Paul Huleatt (Member State Mechanism on Substandard and Falsified Medical Products);

Event Date: 04/12/2024
Location: Virtual
Subject: FDA Application to be a World Health Organization (WHO) Listed Authority
FDA Participant/Group: RAVI BHARWANI
Non FDA Participant/Group: Hiiti Silloh, Rogerio Gaspar (World Health Organization);

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 04/10/2024
Location: Virtual
Subject: The 10th Anniversary American Biomanufacturing Summit; Advanced Manufacturing and Complex Biologic Products
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the 10th Anniversary American Biomanufacturing Summit

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 04/08/2024
Location: Virtual
Subject: Highly Pathogenic Avian Influenza (HPAI)
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Stephanie McBath (National Association of Departments of Agriculture (NASDA));

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 04/08/2024
Location: San Diego, CA
Subject: American Association for Cancer Research Annual Conference; Keynote: FDA’s Comprehensive Approach of Tobacco Regulation
FDA Participant/Group: KARIN RUDOLPH;
Non FDA Participant/Group: Several representatives of the American Association for Cancer Research (AACR) and conference attendees

Event Date: 04/10/2024
Location: Washington, DC
Subject: National Association of Attorneys General’s E-Cigarettes Roundtable; Panelist: Enforcement, the e-Cigarette Marketplace, and Legislative Challenges at the State and Local Levels
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives of the National Association of Attorneys General’s (NAAG)

Event Date: 04/10/2024
Location: Virtual
Subject: Tobacco Product Applications Briefing
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives of the Senate Health, Education, Labor and Pensions (HELP) and staff from Senator Kaine's office

Event Date: 04/11/2024
Location: Washington, DC
Subject: Joint FDA/Department of Justice (DOJ) Briefing on Joint E-Cigarettes, Vapes, and Other Electronic Nicotine Delivery System (ENDS) Enforcement
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Richard Durbin (D-IL) and staff, several representatives from the Department of Justice (DOJ)

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top